Condition: Non-Small-Cell Lung Cancer · Sponsor: BioAtla, Inc.
The objective of this study is to assess safety and efficacy of CAB-AXL-ADC in NSCLC
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| City of Hope - Duarte | Duarte, California, United States | — |
| University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center | Irvine, California, United States | — |
| California Research Institute | Los Angeles, California, United States | — |
| USC Norris | Los Angeles, California, United States | — |
| Cedars-Sinai | Los Angeles, California, United States | — |
| University of California, San Diego (UCSD) - Moores Cancer Center | San Diego, California, United States | — |
| American Institute of Research | Whittier, California, United States | — |
| University of Colorado Anschutz Medical Campus | Aurora, Colorado, United States | — |
| Florida Cancer Specialists & Research Institute | Fleming Island, Florida, United States | — |
| Florida Cancer Specialists & Research Institute | Fort Myers, Florida, United States | — |
| Florida Cancer Specialist | St. Petersburg, Florida, United States | — |
| Moffitt Cancer Center | Tampa, Florida, United States | — |
+ 48 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04681131